Redenlab is pleased to announce that Dr. Adam Vogel, an expert in speech and language function, will be presenting at the 2nd Annual Lysosomal Disease Summit, held at the Pullman & Mercure Melbourne Albert Park, from October 18-20, 2024. This significant event will gather healthcare practitioners and researchers from across Australia and the Asia-Pacific region to address pressing issues in lysosomal disease research and treatment.

Adam will deliver two talks during the event:

• Research Summit: “Speech and Language Function in Pompe Disease”
  • Exploring how Pompe disease impacts speech and language, this presentation will offer new insights into clinical management and research approaches.
• Lysosomal Disease Patient Conference: “Speech and Language Function in Lysosomal Diseases”
  • In this session, Adam will explain how lysosomal diseases affect speech and language across the spectrum, emphasising the need for early diagnosis and effective intervention.

The summit serves as a platform for collaboration, offering participants a chance to network, find research partners, and contribute to the advancement of lysosomal disease care and treatment. With both the scientific and patient communities engaged, it’s an invaluable opportunity to make meaningful strides in the field.

For more information, visit: Lysosomal Disease Summit.

Stay connected as Redenlab continues to push the boundaries of speech research in rare diseases, improving lives through cutting edge science.